1. Home
  2. DUOT vs PLX Comparison

DUOT vs PLX Comparison

Compare DUOT & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duos Technologies Group Inc.

DUOT

Duos Technologies Group Inc.

HOLD

Current Price

$2.72

Market Cap

195.1M

Sector

Technology

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

SELL

Current Price

$2.99

Market Cap

207.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DUOT
PLX
Founded
1990
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
195.1M
207.1M
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
DUOT
PLX
Price
$2.72
$2.99
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
★ $14.83
$12.00
AVG Volume (30 Days)
★ 1.0M
990.1K
Earning Date
11-16-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 53.96
N/A
EPS
★ 1.29
0.31
Revenue
$27,023,651.00
★ $52,744,000.00
Revenue This Year
$81.80
$64.22
Revenue Next Year
$210.28
N/A
P/E Ratio
★ $2.31
$9.85
Revenue Growth
★ 271.16
N/A
52 Week Low
$2.96
$1.65
52 Week High
$15.28
$3.19

Technical Indicators

Market Signals
Indicator
DUOT
PLX
Relative Strength Index (RSI) 21.18 58.37
Support Level N/A $2.08
Resistance Level $9.59 $3.19
Average True Range (ATR) 0.49 0.20
MACD -0.20 0.03
Stochastic Oscillator 2.31 77.54

Price Performance

Historical Comparison
DUOT
PLX

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc delivers AI-driven technologies, edge computing infrastructure, and energy consulting services to support data-intensive and mission-critical operations. It manages, operates, engineers, software development, customer support and project implementation and management across three market segments, including rail technology deployment, Data Center co-location facilities, and behind-the-meter electrical power provision. It also continues to operate as a technology company which designs, develops, deploys, and operates intelligent technology solutions with a focus on software applications and artificial intelligence (AI) in addition to large projects, consulting, implementation, and asset management.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: